26 min
NAFLD/NASH Education Series: Episode 3 - Existing and Emerging Treatments NAFLD/NASH Education Series
-
- Ciência
Join our host, Dr. Amreen Dinani, as we discuss an often undetected liver disease affecting up to 25% of the world's population: nonalcoholic fatty liver disease (NAFLD)and its more severe form, nonalcoholic steatohepatitis(NASH). Each episode, Dr. Dinani is joined by hepatologists from across the United States to talk about the importance of early identification, available diagnostics, and existing and emerging treatments. Whether you're a patient, healthcare professional, or payer, we hope you can join us and learn something new. Learn more at www.nashnetwork.org.
Episode 3 features Dr. Dinani and Dr. Sussman, a hepatologist at Baylor College of Medicine, discussing existing and emerging treatments for NAFLD and NASH. Listeners will learn more about strategies to manage NAFLD and NASH patients and encourage sustainable behaviors, emerging treatment options, and considerations for provider and patient education.
Join our host, Dr. Amreen Dinani, as we discuss an often undetected liver disease affecting up to 25% of the world's population: nonalcoholic fatty liver disease (NAFLD)and its more severe form, nonalcoholic steatohepatitis(NASH). Each episode, Dr. Dinani is joined by hepatologists from across the United States to talk about the importance of early identification, available diagnostics, and existing and emerging treatments. Whether you're a patient, healthcare professional, or payer, we hope you can join us and learn something new. Learn more at www.nashnetwork.org.
Episode 3 features Dr. Dinani and Dr. Sussman, a hepatologist at Baylor College of Medicine, discussing existing and emerging treatments for NAFLD and NASH. Listeners will learn more about strategies to manage NAFLD and NASH patients and encourage sustainable behaviors, emerging treatment options, and considerations for provider and patient education.
26 min